Home / Verticals / Healthcare

Healthcare

Research Reports in Healthcare

Dupixent Market

Dupixent Market Size, Share, & Segmentation By Indication (Atopic Dermatitis (AD), Asthma, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Chronic Obstructive Pulmonary Disease (COPD),...

The dupixent market size was valued at USD 14.18 billion in 2024 and is expected to reach USD 25.70 billion by 2032, growing at a CAGR of 7.74% over 2025-2032.

Date: July 2025 | Report Code: SNS/HC/7818 | Pages: 375
Date: July 2025 | Report Code: SNS/HC/7818 | Pages: 375

Compounding Chemotherapy Market

Compounding Chemotherapy Market Size, Share, & Segmentation By Drug Type (Cytotoxic Drugs, Hormonal Agents, Immunomodulatory Agents, Targeted Therapies, and Supportive Care Drugs), Compou...

The compounding chemotherapy market size was valued at USD 5.63 billion in 2024 and is expected to reach USD 8.73 billion by 2032, growing at a CAGR of 5.65% over 2025-2032.

Date: July 2025 | Report Code: SNS/HC/7816 | Pages: 368
Date: July 2025 | Report Code: SNS/HC/7816 | Pages: 368

Clinical Informatics Market

Clinical Informatics Market Size, Share, & Segmentation By Type (Electronic Health Records, Clinical Trial Management System, Clinical Data Management System, Randomization and Trial Supp...

The clinical informatics market size was valued at USD 230.11 billion in 2024 and is expected to reach USD 755.10 billion by 2032, growing at a CAGR of 16.03% over 2025-2032.

Date: July 2025 | Report Code: SNS/HC/7815 | Pages: 360
Date: July 2025 | Report Code: SNS/HC/7815 | Pages: 360

Veterinary Anti-infectives Market

Veterinary Anti-infectives Market Size, Share & Segmentation, By Animal Type (Livestock Animal and Companion Animal), Product (Antimicrobial, Antifungals, Antivirals, Antiparasitic, and O...

The veterinary anti-infectives market size was valued at USD 8.32 billion in 2024 and is expected to reach USD 13.27 billion by 2032, growing at a CAGR of 6.10% over the forecast period o...

Date: July 2025 | Report Code: SNS/HC/7803 | Pages: 360
Date: July 2025 | Report Code: SNS/HC/7803 | Pages: 360

Breast-Conserving Surgery Market

Breast-Conserving Surgery Market Size, Share & Segmentation, By Procedure (Lumpectomy, Quadrantectomy, and Segmental Mastectomy), Product (Tumor Localization Devices, Surgical Excision De...

The breast-conserving surgery market size was valued at USD 2.36 billion in 2024 and is expected to reach USD 4.18 billion by 2032, growing at a CAGR of 7.47% over the forecast period of ...

Date: July 2025 | Report Code: SNS/HC/7802 | Pages: 328
Date: July 2025 | Report Code: SNS/HC/7802 | Pages: 328

Healthcare IT Services Market

Healthcare IT Services Market Size, Share & Segmentation, By Application (Systems & Network Management, Data Management, Application Management, Security & Compliance Management, and Othe...

The healthcare IT services market size was valued at USD 184.26 billion in 2024 and is expected to reach USD 508.59 billion by 2032, growing at a CAGR of 13.59% over the forecast period o...

Date: July 2025 | Report Code: SNS/HC/7801 | Pages: 328
Date: July 2025 | Report Code: SNS/HC/7801 | Pages: 328

Artificial Ventilation And Anesthesia Masks Market

Artificial Ventilation And Anesthesia Masks Market Size, Share, & Segmentation By Mask (Disposable Masks and Reusable Masks), Application (Operating Rooms, ICU, Emergency Rooms, Homecare,...

The artificial ventilation and anesthesia masks market size was valued at USD 2.37 billion in 2024 and is expected to reach USD 3.54 billion by 2032, growing at a CAGR of 5.15% over 2025-...

Date: July 2025 | Report Code: SNS/HC/7787 | Pages: 355
Date: July 2025 | Report Code: SNS/HC/7787 | Pages: 355

Vyvgart (Efgartigimod) Market

Vyvgart (Efgartigimod) Market Size, Share, & Segmentation By Indication (Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Generalized Myasthenia Gravis (gMG), and Others), Route ...

The Vyvgart (Efgartigimod) market size was valued at USD 2.23 billion in 2024 and is expected to reach USD 6.21 billion by 2032, growing at a CAGR of 13.67% over 2025-2032.

Date: July 2025 | Report Code: SNS/HC/7786 | Pages: 405
Date: July 2025 | Report Code: SNS/HC/7786 | Pages: 405

Tremfya Market

Tremfya Market Size, Share, & Segmentation By Application (Plaque Psoriasis, Psoriatic Arthritis (PsA), and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Onli...

The Tremfya market size was valued at USD 3.73 billion in 2024 and is expected to reach USD 6.71 billion by 2032, growing at a CAGR of 7.63% over 2025-2032.

Date: July 2025 | Report Code: SNS/HC/7785 | Pages: 410
Date: July 2025 | Report Code: SNS/HC/7785 | Pages: 410

Naltrexone And Buprenorphine Market

Naltrexone And Buprenorphine Market Size, Share, & Segmentation By Product (Naltrexone, Buprenorphine (BELBUCA, Sublocade, Suboxone, Zubsolv, and Others), Route of Administration (Naltrex...

The naltrexone and buprenorphine market size was valued at USD 4.20 billion in 2024 and is expected to reach USD 8.54 billion by 2032, growing at a CAGR of 9.30% over 2025-2032.

Date: July 2025 | Report Code: SNS/HC/7779 | Pages: 360
Date: July 2025 | Report Code: SNS/HC/7779 | Pages: 360